A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
An investigational study to determine the safety/tolerability, and efficacy of a notch
signaling pathway inhibitor in patients with metastatic or locally advanced breast cancer and
other advanced solid tumors.